| Date Filed | Type | Description |
| 05/18/2023 |
4/A
| Stewart Robert A (Director) has filed a Form 4 on CorMedix Inc.|
Txns:
| Bought 10,000 shares
@ $4.3735, valued at
$43.7k
|
|
| 05/17/2023 |
4
| Stewart Robert A (Director) has filed a Form 4 on CorMedix Inc.|
Txns:
| Granted 10,000 shares
@ $4.3735, valued at
$43.7k
|
|
| 04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/09/2019 |
4
| Stewart Robert A (President and CEO) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 21,609 shares
@ $13.44, valued at
$290.4k
Exercised 83,277 restricted stock units
@ $0 |
|
| 03/12/2019 |
4
| Stewart Robert A (President and CEO) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Bought 17,000 shares
@ $11.92, valued at
$202.6k
|
|
| 03/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/09/2018 |
4
| Stewart Robert A (President & CEO) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 681,199 options
@ $15.01, valued at
$10.2M
Granted 333,111 restricted stock units
@ $0 |
|
| 05/09/2018 |
3
| Stewart Robert A (President & CEO) has filed a Form 3 on Amneal Pharmaceuticals, Inc. |
| 01/02/2018 |
4
| Stewart Robert A (COO) has filed a Form 4 on Allergan plc|
Txns:
| Paid exercise price by delivering 2,149 shares
@ $163.58, valued at
$351.5k
|
|
| 10/30/2017 |
4
| Stewart Robert A (COO) has filed a Form 4 on Allergan plc|
Txns:
| Exercised 12,427 options to buy
@ $0 |
|
| 04/04/2017 |
4
| Stewart Robert A (COO) has filed a Form 4 on Allergan plc |
| 03/07/2017 |
4
| Stewart Robert A (COO) has filed a Form 4 on Allergan plc |
| 02/03/2017 |
4
| Stewart Robert A (COO) has filed a Form 4 on Allergan plc |
| 03/09/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/03/2014 |
4
| Stewart Robert A (COO) has filed a Form 4 on Actavis plc|
Txns:
| Granted 28,245 options to buy
@ $0
Granted 25,704 options to buy
@ $224, valued at
$5.8M
|
|
| 05/13/2014 |
4
| Stewart Robert A (Pres-Global Operations) has filed a Form 4 on Actavis plc|
Txns:
| Granted 3,383 shares
@ $197.05, valued at
$666.6k
|
|
| 12/10/2013 |
4
| Stewart Robert A (Pres-Global Operations) has filed a Form 4 on Actavis plc|
Txns:
| Sold 8,000 shares
@ $166.02, valued at
$1.3M
|
|
| 11/19/2013 |
4
| Stewart Robert A (Pres-Global Operations) has filed a Form 4 on Actavis plc|
Txns:
| Sold 10,000 shares
@ $164.44, valued at
$1.6M
|
|
| 11/13/2013 |
4
| Stewart Robert A (Pres-Global Operations) has filed a Form 4 on Actavis plc|
Txns:
| Sold 12,000 shares
@ $158.39, valued at
$1.9M
|
|
| 10/03/2013 |
4
| Stewart Robert A (Pres-Global Operations) has filed a Form 4 on Actavis plc|
Txns:
| Granted 71,252 shares
@ $0 |
|
| 10/03/2013 |
3
| Stewart Robert A (Pres-Global Operations) has filed a Form 3 on Actavis plc |
| 10/02/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/13/2013 |
4/A
| Form 4 - Statement of changes in beneficial ownership of securities [amend] |
| 08/06/2013 |
4
| Stewart Robert A (Pres-Global Operations) has filed a Form 4 on Actavis, Inc.|
Txns:
| Paid exercise price by delivering 14,564 shares
@ $136.0202, valued at
$2M
|
|
| 03/08/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/05/2013 |
4
| Stewart Robert A (Pres-Global Operations) has filed a Form 4 on Actavis, Inc.|
Txns:
| Paid exercise price by delivering 4,834 shares
@ $85.54, valued at
$413.5k
|
|
| 03/12/2012 |
4
| Stewart Robert A (Exec VP,Global Operations) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Granted 10,955 shares
@ $0
Granted 8,553 shares
@ $0 |
|
| 02/28/2012 |
4
| Stewart Robert A (Exec VP,Global Operations) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 1,640 shares
@ $58.17, valued at
$95.4k
|
|
| 11/17/2011 |
4
| Stewart Robert A (Exec VP,Global Operations) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 1,622 shares
@ $64.52, valued at
$104.7k
|
|
| 03/04/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/26/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/17/2009 |
4
| Stewart Robert A (Sr VP,Global Operations) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Granted 22,000 shares
@ $0 |
|
| 11/17/2009 |
3
| Stewart Robert A (Sr VP,Global Operations) has filed a Form 3 on WATSON PHARMACEUTICALS INC |